The Motley Fool··Reuben Gregg BrewerMorgan Stanley Backs Eli Lilly's Mounjaro Dominance as International GLP-1 Leader
Morgan Stanley backs Eli Lilly's dominant GLP-1 market position, noting Mounjaro's 50%+ international market share and 10% growth in India despite rival competition.
LLYNVOvaluationmarket share